ArticleVaccines2024

Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial.

Chutima Seree-Aphinan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.